1. Home
  2. SBFM vs REVB Comparison

SBFM vs REVB Comparison

Compare SBFM & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

N/A

Current Price

$1.15

Market Cap

4.3M

Sector

Health Care

ML Signal

N/A

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$1.00

Market Cap

3.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SBFM
REVB
Founded
2006
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.9M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
SBFM
REVB
Price
$1.15
$1.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
393.8K
36.3K
Earning Date
04-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.68
EPS
N/A
N/A
Revenue
$36,305,891.00
N/A
Revenue This Year
$40.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.11
N/A
52 Week Low
$0.25
$0.47
52 Week High
$3.05
$2.32

Technical Indicators

Market Signals
Indicator
SBFM
REVB
Relative Strength Index (RSI) 40.08 45.48
Support Level $1.09 $0.94
Resistance Level $1.29 $1.21
Average True Range (ATR) 0.09 0.06
MACD 0.02 -0.00
Stochastic Oscillator 40.07 43.48

Price Performance

Historical Comparison
SBFM
REVB

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: